Root Financial Partners’s Disc Medicine IRON Stock Holding History

Root Financial Partners’s Portfolio IRON Stock Details IRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$256	Buy	+4	New	+$278	﹤0.01%	3091

Other funds holding IRON

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Root Financial Partners's IRON Position: Q1 2026 in Review

Root Financial Partners opened a new position in Disc Medicine (IRON) in Q1 2026: 4 shares worth $256. The stake represents ﹤0.01% of the portfolio and ranks #3091 among its holdings.

203 funds tracked by Wall St. Rank hold IRON as of Q1 2026.

Root Financial Partners held 4 shares of Disc Medicine worth $256 as of Q1 2026.
Disc Medicine was a new Root Financial Partners position in Q1 2026.
Disc Medicine made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #3091 holding.
203 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.